Company profile · federal money
Neovascularx, Inc.
Neovascularx, Inc. received $305.3K in federal awards in FY2025. Largest customer: Department of Health and Human Services ($305.3K).
- FY2025 federal obligations
- $305.3K
Largest customers: Department of Health and Human Services $305.3K
Data through 2026-09-30; source: USAspending.gov.
Gathering everything on record…
From public government records, which may contain errors. Check the official source before relying on a number. Not financial, legal or investment advice. Terms · About the data
SBIR & STTR awards
1 small-business research award (0 Phase II) worth $305.3K, 2025.
- Topical Ophthalmic Treatment for Neovascular Age-related Macular Degeneration (nAMD) Department of Health and Human Services · SBIR Phase I · $305.3K · 2025
All of its SBIR & STTR awards · SBA's SBIR.gov data